NuVasive, Inc.

473 articles about NuVasive, Inc.

• NuVasive Announces First Quarter 2023 Financial Results

  5/10/2023

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended March 31, 2023.

• NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results

  5/4/2023

  NuVasive, Inc. announced today the Company will release its first quarter 2023 results on Wednesday, May 10, 2023, after the close of the market.

• NuVasive Shareholders Approve Merger Agreement with Globus Medical

  4/27/2023

  NuVasive, Inc. (NASDAQ: NUVA) today announced that at the special meeting of shareholders held earlier today, its shareholders voted to approve the adoption of the Company's merger agreement with Globus Medical (NYSE: GMED).

• Globus Medical Shareholders Approve Share Issuance for Merger with NuVasive

  4/27/2023

  Globus Medical, Inc. announced that at the special meeting of shareholders held earlier today its shareholders voted to approve the issuance of shares of Globus Medical Class A common stock in connection with the proposed merger with NuVasive.

• NuVasive to Participate in Upcoming Global Spine Conferences

  4/11/2023

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced its continued participation at various global conferences throughout April and May.

• NuVasive Specialized Orthopedics Expands Indications of Precice Limb Lengthening System to Treat Pediatric Patients

  3/20/2023

  NuVasive, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the use of its Precice all-internal limb lengthening solution to include pediatric patients*.

• NuVasive to Participate in Upcoming Spine Society Annual Conferences

  3/14/2023

  NuVasive, Inc. today announced its continued participation at the 2023 Spine Summit held March 16-19 in Miami and the International Meeting on Advanced Spine Techniques.

• NuVasive Celebrates 20-Year Milestone of the XLIF Procedure

  3/13/2023

   NuVasive, Inc. announced today the 20-year milestone achievement of its lateral lumbar procedure, extreme lateral interbody fusion (XLIF).

• NuVasive to Participate in Upcoming March 2023 Investor Conferences

  2/27/2023

  NuVasive, Inc. announced that NuVasive management will participate in upcoming investor conferences and will be joined by Globus Medical management to discuss the two companies' recent merger announcement and other business topics.

• NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales Guidance

  2/22/2023

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended December 31, 2022.

• Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care

  2/9/2023

  Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and NUVASIVE (NASDAQ: NUVA), the leader in spine technology innovation, today announced they have entered into a definitive agreement to combine in an all-stock transaction.

• NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2022 Results

  1/30/2023

  NuVasive, Inc. announced today the Company will release its fourth quarter and full-year 2022 results on Wednesday, February 22, 2023 , after the close of the market.

• NuVasive to Participate in the 41st Annual J.P. Morgan Healthcare Conference

  12/12/2022

  NuVasive, Inc. announced today that Chief Executive Officer Chris Barry will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 12, 2023 at 7:30 a.m. PT.

• NuVasive Showcases Latest Innovation in Virtual Global Event

  11/17/2022

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, held a virtual event yesterday showcasing the Company's latest innovation across its market-leading 360 portfolios.

• NuVasive to Participate in Piper Sandler 34th Annual Healthcare Conference

  11/16/2022

  NuVasive, Inc. announced today that Chief Executive Officer Chris Barry will participate in the Piper Sandler 34th Annual Healthcare Conference in New York on Wednesday, November 30, 2022.

• NuVasive to Sponsor and Participate at the Cervical Spine Research Society 50th Annual Meeting

  11/14/2022

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will continue its partnership with the Cervical Spine Research Society (CSRS) as a diamond sponsor and will attend the CSRS 50th Annual Meeting held November 16 to 19 in San Diego.

• NuVasive Announces Third Quarter 2022 Financial Results

  11/9/2022

  NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced financial results for the quarter ended September 30, 2022.

• NuVasive Announces Conference Call and Webcast of Third Quarter 2022 Results

  10/25/2022

  NuVasive, Inc. announced today the Company will release its third quarter financial results on Wednesday, November 9, 2022, after the market close.

• NuVasive to Sponsor and Participate at EUROSPINE 2022

  10/17/2022

  NuVasive, Inc. today announced it will continue its partnership with EUROSPINE as a gold sponsor and will attend EUROSPINE 2022 held October 19 to 21 in Milan.

• NuVasive Announces Agenda for Investor Day 2022

  9/29/2022

  NuVasive, Inc. has announced the planned agenda for the Company's Investor Day 2022, which will be hosted at the NuVasive West Coast Experience Center in San Diego on Thursday, October 6, 2022, with presentations beginning at 9:00 a.m. PT.